A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial
Solomon, Sunil S, Wagner-Cardoso, Sandra, Smeaton, Laura, Sowah, Leonard A, Wimbish, Chanelle, Robbins, Gregory, Brates, Irena, Scello, Christine, Son, Annie, Avihingsanon, Anchalee, Linas, Benjamin, Anthony, Donald, Nunes, Estevão Portela, Kliemann, Dimas A, Supparatpinyo, Khuanchai, Kityo, Cissy, Tebas, Pablo, Bennet, Jaclyn Ann, Santana-Bagur, Jorge, Benson, Constance A, Van Schalkwyk, Marije, Cheinquer, Nelson, Naggie, Susanna, Wyles, David, Sulkowski, Mark
Published in The lancet. Gastroenterology & hepatology (01.04.2022)
Published in The lancet. Gastroenterology & hepatology (01.04.2022)
Get more information
Journal Article
Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D 2 EFT): an open-label, randomised, phase 3b/4 trial
Published in The lancet HIV
(01.07.2024)
Get more information
Journal Article